Clinical Trial Update: Additional Measles Vaccine at 4 Months of Age [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating an additional measles vaccine dose administered at 4 months of age.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Measles

Drugs mentioned

• Measles vaccine (Measles vaccine)

Snippet

Sponsor: Bandim Health Project | Conditions: Measles Infection | Phase 4 | Status: UNKNOWN